Keurig Dr Pepper (NASDAQ:KDP) Stock Gets Price Target Bump from Barclays

Keurig Dr Pepper (NASDAQ:KDP) had its price objective lifted by research analysts at Barclays from $38.00 to $41.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Barclays‘s price objective would indicate a potential upside of 11.34% from the company’s current price.

Several other research analysts also recently commented on the stock. TD Cowen raised their price target on shares of Keurig Dr Pepper from $33.00 to $35.00 and gave the company a “hold” rating in a report on Wednesday. UBS Group increased their price target on shares of Keurig Dr Pepper from $39.00 to $42.00 and gave the company a “buy” rating in a research report on Wednesday. Wells Fargo & Company raised their price target on Keurig Dr Pepper from $37.00 to $40.00 and gave the stock an “overweight” rating in a research report on Wednesday. Piper Sandler reissued an “overweight” rating on shares of Keurig Dr Pepper in a report on Wednesday, October 14th. Finally, Argus reiterated a “buy” rating and set a $36.00 price objective on shares of Keurig Dr Pepper in a research report on Tuesday, September 15th. Ten analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $37.29.

Keurig Dr Pepper Trading Up 0.1%

NASDAQ:KDP traded up $0.04 during mid-day trading on Thursday, hitting $36.83. 11,733,231 shares of the company’s stock were exchanged, compared to its average volume of 12,299,308. The firm has a market capitalization of $50.11 billion, a P/E ratio of 33.77, a PEG ratio of 1.65 and a beta of 0.35. The company has a current ratio of 0.52, a quick ratio of 0.28 and a debt-to-equity ratio of 0.73. Keurig Dr Pepper has a fifty-two week low of $24.88 and a fifty-two week high of $37.88. The company has a 50 day simple moving average of $32.68 and a 200-day simple moving average of $30.11.

Keurig Dr Pepper (NASDAQ:KDP) last issued its earnings results on Tuesday, November 3rd. The company reported $0.66 earnings per share for the quarter, topping analysts’ consensus estimates of $0.62 by $0.04. Keurig Dr Pepper had a return on equity of 11.27% and a net margin of 7.12%. The business had revenue of $7.34 billion during the quarter, compared to the consensus estimate of $7.33 billion. During the same period in the previous year, the company posted $0.54 earnings per share. The firm’s revenue for the quarter was up 70.6% on a year-over-year basis. As a group, research analysts expect that Keurig Dr Pepper will post 2.30 earnings per share for the current year.

Insider Buying and Selling

In other Keurig Dr Pepper news, Director Aaron E. Alt acquired 7,862 shares of the firm’s stock in a transaction dated Tuesday, August 25th. The stock was purchased at an average price of $31.83 per share, for a total transaction of $250,247.46. Following the acquisition, the director owned 7,862 shares in the company, valued at approximately $250,247.46. This trade represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Mary Beth Denooyer sold 12,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $32.55, for a total transaction of $390,600.00. Following the sale, the insider directly owned 84,171 shares in the company, valued at approximately $2,739,766.05. This represents a 12.48% decrease in their position. The SEC filing for this sale provides additional information. 0.34% of the stock is owned by insiders.

Institutional Investors Weigh In On Keurig Dr Pepper

Hedge funds and other institutional investors have recently made changes to their positions in the company. Keybank National Association OH grew its stake in Keurig Dr Pepper by 3.0% in the 3rd quarter. Keybank National Association OH now owns 18,876 shares of the company’s stock valued at $573,000 after acquiring an additional 557 shares during the period. Csenge Advisory Group acquired a new position in Keurig Dr Pepper during the third quarter worth $286,000. AlphaCore Capital LLC raised its position in Keurig Dr Pepper by 58.8% during the third quarter. AlphaCore Capital LLC now owns 20,196 shares of the company’s stock worth $613,000 after acquiring an additional 7,476 shares during the period. Retirement Systems of Alabama lifted its holdings in Keurig Dr Pepper by 664.0% during the third quarter. Retirement Systems of Alabama now owns 2,183,609 shares of the company’s stock valued at $66,251,000 after purchasing an additional 1,897,787 shares in the last quarter. Finally, Fulcrum Asset Management LLP lifted its holdings in Keurig Dr Pepper by 1,691.7% during the third quarter. Fulcrum Asset Management LLP now owns 3,225 shares of the company’s stock valued at $100,000 after purchasing an additional 3,045 shares in the last quarter. Institutional investors and hedge funds own 93.99% of the company’s stock.

Key Stories Impacting Keurig Dr Pepper

Here are the key news stories impacting Keurig Dr Pepper this week:

• Positive Sentiment: Barclays reaffirmed its Buy rating. UBS raised its target to $42 and kept a Buy rating; JPMorgan raised its target to $41 with an Overweight rating, and Morgan Stanley lifted its target to $40, also maintaining Overweight. These calls reinforce optimism about KDP’s prospects. Barclays reaffirms Buy rating
• Positive Sentiment: Energy-drink market share topped 10% following brand acquisitions, and beverage growth helped KDP beat Q3 earnings expectations. The JDE Peet’s acquisition also boosted reported sales growth. Three key takeaways for long-term investors
• Neutral Sentiment: KDP is planning to separate its coffee and beverage businesses in early 2027. The move could help investors value the different businesses independently, but the split’s eventual impact remains uncertain. The company expects 2026 net sales of $25.9 billion to $26.4 billion. 2026 sales outlook and planned separation
• Negative Sentiment: Coffee demand is soft, with shoppers trading down, and KDP warned of slower U.S. coffee profits in Q4. Q3 sales also fell short of forecasts, tempering the earnings beat. TD Cowen raised its target to $35 but kept a Hold rating, signaling caution at the stock’s recent valuation. KDP flags slower fourth-quarter coffee profits

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc (NASDAQ: KDP) is a beverage company that operates across coffee and packaged beverages. Its portfolio includes soft drinks, flavored waters, juices, juice drinks, ready-to-drink teas and coffees, sports and energy beverages, and mixers, as well as single-serve coffee brewing systems and pods.

The company’s brands include Keurig, Green Mountain Coffee Roasters, The Original Donut Shop, Dr Pepper, Canada Dry, Snapple, 7UP, A&W, Mott’s, Bai, CORE Hydration and Venom, among others.